ArticleOncotarget2017

Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients.

Mariano Provencio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.